Nobilis Health Corp.
NRTSF · OTC
6/30/2018 | 3/31/2018 | 12/31/2017 | 9/30/2017 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.3% | -25.7% | 34.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.4% | 59.4% | 64.9% | 59.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 6% | -4.3% | 19.3% | 2% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | -$0 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 1.3% | -6% | 4.1% | 1.6% |
| EPS | 0.01 | -0.049 | 0.05 | 0.01 |
| % Growth | 120.3% | -198.6% | 400% | – |
| EPS Diluted | 0.01 | -0.049 | 0.05 | 0.01 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.5% | 5.8% | 23.8% | 6.3% |